Merck, Daiichi repeat early success in small cell lung cancer with updated ADC data
Terns Pharmaceuticals' oral obesity drug shows promise in early study, shares jump
GSK's long-acting asthma drug halved attacks in phase 3
Candid, with $370M, sets out to prove bispecifics’ worth in autoimmune disease
*please scroll down for all the latest news*
